RE:Fascinating
Investorpedia wrote: Report date announced, and SP goes south.
Same pattern emerged with Auxly's last two quarterly reports. A week or so of accumulation then a dump two trading days before the Report.
Definitely weird! No manipulation going on though. That's not possible, riiight??
The entire mj sector is being forked over right now as key legislation is awaited in the US., regulatory changes are pending in Canada and Germany works to establish first time recreational regulations for cannabis.
Seems the only thing not strictly controlled in the world of cannabis is the way the MMs mangle the market.
AUXLY's Q1-2022 should see a vast Net Rev improvement over 2021's Q1.
Cash balance and EBITDA will be the focus of attention. It's all about the money this year as Auxly strives to generate profits.
Regardless of how stellar any recent achievements might be the over arcing Cannabis Carnage that continues along with a full bear market due to oligarchs, inflation and interest rates, leaves limited immediate upside potential right now. Patience is the average investors only friend right now.
All markets are now at the mercy of the mega rich.
Provided they demonstrate continuous progress moving forward, Auxly remains a long play at these levels with the potential for significant returns.
In times like these I'm looking for beat down blue chips to buff up passive income as well as emerging unicorns.
Future forward!
cheers